The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 40 | — | 20.1x | Near average | |
Growth | 78 | — | 5.6% | Above average | |
Quality | 51 | 598.3% | 7.6% | Near average | |
Safety | 22 | 0.5x | 0.4x | Below average | |
Capital Return | 96 | — | 2.19% | Above average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
KALA BIO, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy KALA BIO, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
KALA BIO stock shows a state of high uncertainty with a sharp decline in analyst coverage, as current forecasts are limited to only one analyst with a price target of 18.25 dollars. Although this target reflects significant theoretical optimism compared to the current price (2.43 dollars), the lack of consensus and the cessation of periodic updates weaken the reliability of this figure as an investment benchmark.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.